Read More

DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round

The Biopharmaceutical Research Company (BRC), an active DEA pharmaceutical cannabis license holder, announced the completion of a $20 million Series A fundraise, that will enable the company to scale its operations and increase its product offering, conduct sponsored research, and execute on its go-to-market strategy.

GSK

Read More

Discover Consumers Sentiment & Buyer Behavior With Brightfield Group’s New Cannabis Platform

Software as a service cannabis platform Brightfield Group confirmed Tuesday the launch of its Cannabis Brand Health Platform. This new solution provides an in-depth view of brand health derived from first-party consumer data, allowing cannabis brands across the United States to optimize their brand strategy by tracking how cons

AAWH